Abstract |
HIV-1 proteinase activity is thought to occur primarily post-integration by cleaving the viral Gag and Gag- Pol polyproteins. Its role in the pre-integration stages of viral replication, however, has not been studied in detail. Here we report that a synthetic peptide analogue, UK-88,947, which is a specific inhibitor of purified HIV-1 proteinase, inhibits the processing of the viral polyproteins in cultures of HIV-1 infected cells and prevents the formation of mature, infectious virions. Analysis of DNA from HIV-1 infected cells treated with UK-88,947 showed that viral DNA synthesis was inhibited when the compound was added to cultures one hour before infection. Similar results were obtained when AZT was used. Neither HIV-1 reverse transcriptase or the replication of FIV are inhibited by UK-88,947.
|
Authors | C Baboonian, A Dalgleish, L Bountiff, J Gross, S Oroszlan, G Rickett, C Smith-Burchnell, P Troke, J Merson |
Journal | Biochemical and biophysical research communications
(Biochem Biophys Res Commun)
Vol. 179
Issue 1
Pg. 17-24
(Aug 30 1991)
ISSN: 0006-291X [Print] United States |
PMID | 1652947
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- DNA, Viral
- HIV Protease Inhibitors
- Oligonucleotide Probes
- Oligopeptides
- Recombinant Proteins
- UK 88947
- Zidovudine
- HIV Protease
|
Topics |
- Amino Acid Sequence
- Base Sequence
- Cell Line
- DNA, Viral
(biosynthesis, genetics)
- HIV Protease
(metabolism, pharmacology)
- HIV Protease Inhibitors
- HIV-1
(enzymology, genetics, physiology)
- Humans
- Immunodeficiency Virus, Feline
(drug effects, physiology)
- Molecular Sequence Data
- Oligonucleotide Probes
- Oligopeptides
(pharmacology)
- Proviruses
(genetics, physiology)
- Recombinant Proteins
(metabolism)
- Substrate Specificity
- Virus Replication
(drug effects)
- Zidovudine
(pharmacology)
|